GENEVA, July 1 -- SHENZHEN HIGHTIDE BIOPHARMACEUTICAL LTD. filed a patent application (CN2025/140597) for “MUTLIFUNCTIONAL DRUG CONJUGATE OF GEMFIBROZIL AND A MITOCHONDRIAL UNCOUPLER, AND COMPOSITIONS AND METHODS THEREOF”. With publication no. WO/2026/124387, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07C 205/37

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....